Astrazeneca Plc | AZN

AI Analysis of Astrazeneca Plc

Astrazeneca had a nice pop today and is currently up 3.03% we'll see if the cash keeps flowing in.

Currently AZN isn't at a clear support/resistance line that seems tradable. Astrazeneca hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. AZN might find some support at the 182.63 level, buyers might push the price back up from here. But it's not very clear what will happen.

Last analyzed on 2026-07-23

Companies with the highest correlation to Astrazeneca

Company	Score	1 Day%	5 Day	1 Month	3 Month	6 Month	1 Year	RSI	3mo S-momo ? Smooth Momentum is our proprietary technical indicator that looks for momentum with the greatest consistency and steady velocity. We have penalized dramatic swings and fluctuations. If the momentum is too high and an asset spikes upward, this is often unreliable and collapses back down. But the smoothed momentum provides the highest probability of continuing into the near future with the same directional rate of change. Several complex factors are weighted by neural nets to maximize probabilistic accuracy. It works the same with positive or negative directions.	6mo S-momo	1yr S-momo	Resistance ? Support and Resistance levels are determined by previous high and low points. You may be familiar with traders drawing lines across charts where several peaks or valleys occur in the same range. This helps us understand the trading range of an asset where the market doesn't perceive it to be worth more or less than a certain price level. When it nears the boundaries of this range the probability of reversal can increase. Our neural nets create scores for this measure based on many factors such as the frequency, recency, size, consistency, etc of previous reversal points.	Support	Demark Buy	Short Interest Score
GSK \| GSK plc American Deposita	0.76	3.38	4.82	4.22	2.68	-13.10	33.47	36	1.48	2.45	9.08	-5846.10	-175.44	125	0.713672
SNY \| Sanofi American Depositar	0.67	1.91	4.68	5.70	3.81	-3.27	-8.69	54	-22.51	-24.20	-30.38	299.38	-2854.36	0	1.74425
NVS \| Novartis AG	0.34	3.73	5.66	2.67	6.31	-2.20	28.30	50	7.74	13.34	22.92	-3325.74	-28734.90	0	1.25704
LLY \| Eli Lilly & Co.	0.33	4.46	5.90	7.97	20.25	25.13	82.07	45	41.71	34.02	62.58	-2106.00	-18143.71	0	1.54682
ABBV \| ABBVIE INC.	0.33	2.72	6.04	3.52	24.80	18.55	28.99	65	18.86	15.33	20.17	-436.46	-22806.12	0	2.04137
MRK \| Merck & Co., Inc.	0.29	12.60	12.28	16.65	27.13	24.90	79.21	57	28.77	42.97	65.41	-797.03	-25784.79	0	1.61713
NVO \| Novo-Nordisk A/S	0.27	1.68	-0.51	-3.53	5.18	-4.07	-15.15	38	1.62	0.28	-6.90	-31727.15	-5060.75	0	0.771599

Top 3 correlating companies

See full charts for all peers

Legal Disclaimer: The services provided are for general informational purposes only. None of the service is intended as investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security, or fund. The Services should not be relied upon for purposes of transacting securities or other investments. We cannot and do not assess or guarantee the suitability or profitability of any particular investment, or the potential value of any investment or informational source. You bear responsibility for your own investment research and decisions, and should seek the advice of a qualified securities professional before making any investment. Many traders who receive free or paid content will make little or no money. Any results displayed are exceptional and are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Do not invest money you cannot afford to lose. We do not guarantee any outcome regarding your earnings or income as the factors that impact such results are numerous and uncontrollable.

Research

Estimates

Ratings

Short Interest

Smart Money

Options

Financials

Social

Misc